Medicinal Products

Abakavir/Lamivudin Mylan 600 mg/300 mg filmom obložene tablete

Name Abakavir/Lamivudin Mylan 600 mg/300 mg filmom obložene tablete
Marketing Authorisation Number HR-H-721934245
Active Substance abacavirum, lamivudinum
Pharmaceutical Form filmom obložena tableta
Strength 600 mg + 300 mg
Packaging [MA Number for Packaging] 30 tableta u blisteru, u kutiji  [HR-H-721934245-01]
60 tableta u blisteru, u kutiji  [HR-H-721934245-02]
90 tableta u blisteru, u kutiji  [HR-H-721934245-03]
30 tableta u bočici, u kutiji  [HR-H-721934245-04]
Manufacturer Mylan S.A.S., Saint Priest, Francuska;
McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin, Dublin, Irska
Marketing Authorisation Holder Mylan S.A.S., 117 allee des Parcs, Saint Priest, Francuska
Marketing Authorisation Date 11.06.2018
MA Period of Validity 11.06.2023
Classification Number UP/I-530-09/16-01/307
Registration Number 381-12-01/38-18-10
Composition jedna filmom obložena tableta sadrži 600 mg abakavira (u obliku abakavirklorida) i 300 mg lamivudina
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code J05AR02
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Prezentacija za zdravstvene radnike, verzija 3
Back